Free Newsletter
PATH finds cheap method to guard vax stocks
Seattle-based PATH has been working on ways to improve the world's "cold chain," a long and fragile supply line that runs from manufacturers to villages and towns all around the world. Vaccines have to be stored and transported at a steadily cool temperature, and any variation in temperature--up or down--can easily destroy the vaccine's effectiveness.
"Every country we've gone into to look at this says they don't have a problem with it, and every time we look into it, we find they do," PATH's Debbie Kristensen told the Seattle Post-Intelligencer.
PATH's mission in life is to find cheap ways to come up with effective and cheap solutions to health problems, and they have found that there are some simple measures that work to guard vaccine stocks. They found that the commonly available food ingredients glycerin, propylene glycol and polyethylene glycol can protect vaccines from freezing. This kind of cheap antifreeze--which costs about a penny per 10 jabs--can work in the developing world as well as the U.S.
- check out the report in the Seattle Post-Intelligencer
Related Article:
Malaria trials will pay volunteers to get infected
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




